Taiwan Bio Therapeutics Co., Ltd (6892.TWO) stock: key figures, P/E, revenue and dividend
Health Care · Taiwan · ISIN TW0006892003
Price
26.50 TWD
Market cap
2.25 bn TWD
P/E (2025)
–
P/S (2025)
44.62
Dividend yield
0.00 %
Net margin
-756.85 %
Return on equity (ROE)
-52.31 %
Return on assets (ROA)
-28.17 %
Taiwan Bio Therapeutics Co., Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 105.09 m TWD | 50.43 m TWD |
| Gross profit | 56.07 m TWD | 32.14 m TWD |
| Operating income | -351.44 m TWD | -384.27 m TWD |
| EBIT | -346.59 m TWD | -374.51 m TWD |
| Net income | -351.80 m TWD | -381.65 m TWD |
| Diluted EPS – continuing operations | -4.72 TWD | -4.50 TWD |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Taiwan Bio Therapeutics Co., Ltd
Taiwan Bio Therapeutics Co., Ltd., regenerative medicine company, focuses on the development of new cell medicines. It offers medicines for degenerative diseases, cardiovascular diseases, diabetes complications, and autoimmune diseases. The company was founded in 2014 and is based in Taipei, Taiwan.
More stocks
- Lumir Inc. (474170.KQ)
- Midnight Sun Mining Corp (MMA.V)
- Apex Science & Engineering Corp (3052.TW)
- Heidmar Maritime Holdings Corp. Common Stock (HMR)
- DreamCIS Inc (223250.KQ)
- Hyundai E P (089470.KS)
- Daelim Paper Co.Ltd (017650.KQ)
- Halla Eng&Cons (014790.KS)
- Woosu AMS Co.Ltd (066590.KQ)
- P.A. Resources Bhd (7225.KL)
- Mercury Biopharmaceutical Corporation (6932.TWO)
- Mindax Ltd (MDX.AX)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.